Krystal Biotech, Inc. 8-K Report: Key Updates from February 19, 2025

Here are the key insights extracted from the provided section of the financial report:

1. Entity Identification:

• Company Name: Krystal Biotech, Inc.
• CIK Number: 0001711279
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-38210
• EIN (Employer Identification Number): 82-1080209

2. Document Type:

• Filing Type: 8-K (Current Report)

3. Filing Date:

• Date of Report: February 19, 2025

4. Contact Information:

• Address: 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203
• Phone Number: 412-586-5830

5. Period Covered:

• Start Date: February 19, 2025
• End Date: February 19, 2025

6. XML and XBRL References:

• The report is formatted in XBRL (eXtensible Business Reporting Language), which is used for electronic filing with the SEC.

Insights:

• The 8-K filing indicates that Krystal Biotech, Inc. is reporting a significant event or update on the specified date. Such filings typically include information about corporate events, financial performance, or other significant changes impacting the company.
• The use of XBRL suggests that the company is adhering to modern reporting standards, which enhances the accessibility and usability of financial data for investors and analysts.
• The address indicates the company is based in Pittsburgh, Pennsylvania, which may be relevant for regional market analysis or understanding local economic conditions impacting the company.

Conclusion:

This section of the financial report provides essential details about Krystal Biotech, Inc.'s filing, including its identification, the nature of the report (8-K), and the timeline for the information reported. Further analysis would be needed to understand the content of the report itself for insights on the company's current events or performance.